189 related articles for article (PubMed ID: 22234985)
1. The cyclin-dependent kinase inhibitor roscovitine inhibits kinase activity, cell proliferation, multicellular development, and Cdk5 nuclear translocation in Dictyostelium discoideum.
Huber RJ; O'Day DH
J Cell Biochem; 2012 Mar; 113(3):868-76. PubMed ID: 22234985
[TBL] [Abstract][Full Text] [Related]
2. The cyclin-dependent kinase family in the social amoebozoan Dictyostelium discoideum.
Huber RJ
Cell Mol Life Sci; 2014 Feb; 71(4):629-39. PubMed ID: 23974243
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.
Liebl J; Krystof V; Vereb G; Takács L; Strnad M; Pechan P; Havlicek L; Zatloukal M; Fürst R; Vollmar AM; Zahler S
Angiogenesis; 2011 Sep; 14(3):281-91. PubMed ID: 21487803
[TBL] [Abstract][Full Text] [Related]
4. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
Goodyear S; Sharma MC
Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.
Price DA; Sorkin A; Zahniser NR
Mol Pharmacol; 2009 Oct; 76(4):812-23. PubMed ID: 19628755
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 5 is a calmodulin-binding protein that associates with puromycin-sensitive aminopeptidase in the nucleus of Dictyostelium.
Huber RJ; Catalano A; O'Day DH
Biochim Biophys Acta; 2013 Jan; 1833(1):11-20. PubMed ID: 23063531
[TBL] [Abstract][Full Text] [Related]
7. Cdk5 inhibits anterograde axonal transport of neurofilaments but not that of tau by inhibition of mitogen-activated protein kinase activity.
Moran CM; Donnelly M; Ortiz D; Pant HC; Mandelkow EM; Shea TB
Brain Res Mol Brain Res; 2005 Apr; 134(2):338-44. PubMed ID: 15836929
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats.
Li G; Liu T; Kong X; Wang L; Jin X
J Mol Neurosci; 2014 Sep; 54(1):92-9. PubMed ID: 24563226
[TBL] [Abstract][Full Text] [Related]
9. [Caspase-3 plays a required role in PC12 cell apoptotic death induced by roscovitine].
Gao JX; Zhou YQ; Zhang RH; Ma XL; Liu KJ
Sheng Li Xue Bao; 2005 Dec; 57(6):755-60. PubMed ID: 16344902
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
[TBL] [Abstract][Full Text] [Related]
11. The Cdk5 inhibitor roscovitine strongly inhibits glucose uptake in 3T3-L1 adipocytes without altering GLUT4 translocation from internal pools to the cell surface.
Muruáis G; Lalioti V; Sandoval IV
J Cell Physiol; 2009 Jul; 220(1):238-44. PubMed ID: 19326393
[TBL] [Abstract][Full Text] [Related]
12. Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9.
Berberich N; Uhl B; Joore J; Schmerwitz UK; Mayer BA; Reichel CA; Krombach F; Zahler S; Vollmar AM; Fürst R
Br J Pharmacol; 2011 Jul; 163(5):1086-98. PubMed ID: 21391976
[TBL] [Abstract][Full Text] [Related]
13. CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes.
Nakano N; Nakao A; Ishidoh K; Tsuboi R; Kominami E; Okumura K; Ogawa H
Br J Dermatol; 2005 Jul; 153(1):37-45. PubMed ID: 16029324
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
Otyepka M; Bártová I; Kríz Z; Koca J
J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
[TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic transfer of cyclin dependent kinase 5 and its binding to puromycin-sensitive aminopeptidase in Dictyostelium discoideum.
Huber RJ; O'Day DH
Histochem Cell Biol; 2011 Aug; 136(2):177-89. PubMed ID: 21766205
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5.
Sharma MR; Tuszynski GP; Sharma MC
J Cell Biochem; 2004 Feb; 91(2):398-409. PubMed ID: 14743398
[TBL] [Abstract][Full Text] [Related]
17. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models.
Menn B; Bach S; Blevins TL; Campbell M; Meijer L; Timsit S
PLoS One; 2010 Aug; 5(8):e12117. PubMed ID: 20711428
[TBL] [Abstract][Full Text] [Related]
18. Small molecule cyclin-dependent kinase inhibitors protect against neuronal cell death in the ischemic-reperfused rat retina.
Sakamoto K; Ohki K; Saito M; Nakahara T; Ishii K
J Ocul Pharmacol Ther; 2011 Oct; 27(5):419-25. PubMed ID: 21714634
[TBL] [Abstract][Full Text] [Related]
19. Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension.
Planchais S; Glab N; Tréhin C; Perennes C; Bureau JM; Meijer L; Bergounioux C
Plant J; 1997 Jul; 12(1):191-202. PubMed ID: 9263460
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
